RT Journal Article SR Electronic T1 Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.25.21250463 DO 10.1101/2021.01.25.21250463 A1 Bonnie A. Thiel A1 William Worodria A1 Sophie Nalukwago A1 Mary Nsereko A1 Ingvar Sanyu A1 Lalitha Rejani A1 Josephine Zawedde A1 David H Canaday A1 Catherine M Stein A1 Keith A Chervenak A1 LaShaunda L Malone A1 Ronald Kiyemba A1 Richard F Silver A1 John L Johnson A1 Harriet Mayanja-Kizza A1 W Henry Boom YR 2021 UL http://medrxiv.org/content/early/2021/04/05/2021.01.25.21250463.abstract AB Background The search for immune correlates of protection against Mycobacterium tuberculosis (MTB) infection in humans is limited by the focus on peripheral blood measures. Bronchoalveolar lavage (BAL) can safely be done and provides insight into cellular function in the lung where infection is first established. In this study, blood and lung samples were assayed to determine if heavily MTB exposed persons who resist development of latent MTB infection (RSTR) vs those who develop latent MTB infection (LTBI), differ in the make-up of resident BAL innate and adaptive immune cells.Methods Bronchoscopy was performed on 21 healthy long-term Ugandan RSTR and 25 LTBI participants. Immune cell distributions in BAL and peripheral blood were compared by differential cell counting and flow cytometry.Results The bronchoscopy procedure was well tolerated with few adverse reactions. Differential macrophage and lymphocyte frequencies in BAL differed between RSTR and LTBI. When corrected for age, this difference lost statistical significance. BAL CD4+ and CD8+ T cells were almost entirely composed of effector memory T cells in contrast to PBMC, and did not differ between RSTR and LTBI. BAL NKT, γδ T cells and NK cells also did not differ between RTSR and LTBI participants. There was a marginally significant increase (p=0.034) in CD8 T effector memory cells re-expressing CD45RA (TEMRA) in PBMC of LTBI vs RSTR participants.Conclusion This observational case-control study comparing unstimulated BAL from RSTR vs LTBI, did not find evidence of large differences in the distribution of baseline BAL immune cells. PBMC TEMRA cell percentage was higher in LTBI relative to RSTR suggesting a role in the maintenance of latent MTB infection. Functional immune studies are required to determine if and how RSTR and LTBI BAL immune cells differ in response to MTB.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) UO1AI115642, RO1AI124348 and NIAID Contract 75N93019C00071. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was reviewed and approved by the institutional review boards of the Makerere University School of Biomedical Sciences and University Hospitals Cleveland Medical Center. All participants gave written informed consent for study participation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in the manuscript are available in the supplemental files.